Assignee
DENDROGENIX
BE·0 granted patents·3 pending applications·0 citations·filing 2020–2021
Top patents by PatentIndex Score
3 records- 0146US2023391817A15alpha-hydroxy-6beta-[2-(1-h-imidazol-4-yl)-ethylamino]-cholestan-3beta-ol analogues and pharmaceutical compositions comprising same for use in the treatment of cancerDENDROGENIX·Filed 2021·Application pending·0 cites
- 0246US2024002429A1PRODRUG OF 5a-HYDROXY-6ß-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3ß-OL AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME FOR USE IN THE TREATMENT OF CANCERDENDROGENIX·Filed 2021·Application pending·0 cites
- 0339US2022313706A1Composition comprising sterol derivatives for use in the treatment of a neuronal pathology related to hypoxia, hypoglycemia and/or hyperglycemiaDENDROGENIX·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DENDROGENIX files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →